Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

about

Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review Cytomegalovirus related fatal duodenal diverticular bleeding: Case report and literature review.

P2860

Q36265398-FAF23E01-2E11-4B34-AF4C-DF791A6B6E75 Q37183007-DF930843-BF38-4E37-BC04-E0E6CBB76A7B

P2860

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

Item

http://www.wikidata.org/entity/Q38364698

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Efficacy of valganciclovir and ...... transplants: A meta-analysis.

@en

type

Item

label

Efficacy of valganciclovir and ...... transplants: A meta-analysis.

@en

prefLabel

Efficacy of valganciclovir and ...... transplants: A meta-analysis.

@en

P1476

Efficacy of valganciclovir and ...... transplants: A meta-analysis.

@en

P2093

Alireza Janbakhsh

http://www.w3.org/2001/XMLSchema#string

Babak Sayyad

http://www.w3.org/2001/XMLSchema#string

Farid Najafi

http://www.w3.org/2001/XMLSchema#string

Feizolla Mansouri

http://www.w3.org/2001/XMLSchema#string

Mandana Afsharian

http://www.w3.org/2001/XMLSchema#string

Siavash Vaziri

http://www.w3.org/2001/XMLSchema#string

Zohre Pezhman

http://www.w3.org/2001/XMLSchema#string

P2860

Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy

Valganciclovir prophylaxis in patients at high risk for the development of cytomegalovirus disease.

Treatment of cytomegalovirus infection or disease in solid organ transplant recipients with valganciclovir.

Efficacy and safety of low-dose valganciclovir in the prevention of cytomegalovirus disease in adult liver transplant recipients.

Experience with low-dose valganciclovir prophylaxis in adult liver transplant recipients.

Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection.

Antiviral resistance in cytomegalovirus: an emerging problem in organ transplant recipients.

P304

1185-1192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25709661

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

4333528

http://www.w3.org/2001/XMLSchema#string

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

about

P2860

P2860

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932